0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Contribution |

Spinocerebellar Ataxia Type 2:  Clinical Features of a Pedigree Displaying Prominent Frontal-Executive Dysfunction FREE

Elsdon Storey, PhD; Susan M. Forrest, PhD; Janet H. Shaw, BS; Peter Mitchell, FRACR; R. J. McKinley Gardner, FRACP
[+] Author Affiliations

From the Department of Neuroscience, Monash University (Alfred Hospital Campus), Prahran (Dr Storey); Victorian Clinical Genetics Service (Drs Storey and Gardner) and Murdoch Institute (Drs Forrest and Gardner and Ms Shaw), Royal Children's Hospital, Parkville; and Department of Radiology, The Royal Melbourne Hospital, Parkville (Dr Mitchell), Australia.


Arch Neurol. 1999;56(1):43-50. doi:10.1001/archneur.56.1.43.
Text Size: A A A
Published online

Background  Spinocerebellar ataxia type 2 (SCA2) is a recently delineated cause of autosomal dominant cerebellar ataxia type I. The basic clinical neurologic features of SCA2 have been described in the literature, but neuropsychological features have not, despite statements that some patients became demented.

Objective  To describe the clinical and neuropsychogical features of patients from a pedigree with SCA2.

Patients and Methods  We studied 8 affected members of an Australian pedigree of northern Italian origin with autosomal dominant cerebellar ataxia type I caused by SCA2. Patients underwent clinical neurologic examination and abbreviated neuropsychological testing, while some also underwent magnetic resonance imaging. The results were compared with pooled results from previously published studies of patients with SCA2.

Results  The pedigree displayed anticipation, with earlier onset in later generations, and there was an inverse correlation between repeat number and age at onset. The principal difference from other clinical reports of SCA2 was our finding of unequivocal frontal-executive dysfunction in 5 of 6 individuals who could be tested quantitatively, despite Mini-Mental State Examination scores in the nondemented range. This feature did not appear to correlate with either repeat size or duration of illness.

Conclusions  In light of a recent report of frontal-executive dysfunction in spinocerebellar ataxia type III, we postulate that this pattern may be common to the autosomal dominant cerebellar ataxias and frequently may be overlooked because of the insensitivity of routine screening tests such as the Mini-Mental State Examination.

Figures in this Article

THE CLASSIFICATION of the predominantly adult-onset dominant ataxias has been revolutionized by the discovery of a number of genes, mapped or actually identified, for disorders designated as spinocerebellar ataxias (SCAs) type 1 through 7.1 Of these, the genes for SCAs 1, 2, 3, and 7 have been sequenced, and they share a common triplet repeat amplification with polyglutamine tract expansion mechanism.1 Spinocerebellar ataxia type 6 is also caused by expansion of a polyglutamine tract, but it appears to have a rather different pathogenetic basis.2

Before these advances in the molecular biology of the dominant ataxias, a clinical classification proposed by Harding3 was widely used. Her autosomal dominant cerebellar ataxia type I (ADCA I) group consisted of pedigrees with other neurologic features in addition to ataxia (eg, dementia, ophthalmoplegia, peripheral neuropathy), except retinal degeneration. (The latter was a remarkably consistent feature in certain pedigrees and was separately designated as ADCA II, now known to correspond to SCA7.) The SCAs 1 through 4, and some cases of SCA6, presumably together with other SCAs whose genes are as yet unlocalized, correlate with ADCA I.

The clinical appearance now associated with SCA2 was probably first recognized as a distinct entity by Wadia and Swami,4 who described dominant ataxia with slow eye movements in families from Mumbai (formerly Bombay), India. In 1989, Orozco et al5 described a large pedigree with similar clinical features from Holguin in Cuba, which subsequently enabled localization of the responsible gene, now designated SCA2, to chromosome 12q23-24.1.6 In the same year, anticipation in an SCA2 kindred was demonstrated,7 suggesting that triplet repeat expansion might underlie this disorder. This inference received support when a 150-kd protein from affected patients was detected by Western blotting by means of a monoclonal antibody recognizing expanded polyglutamine tracts.8 Finally, the gene sequence itself was reported by 3 groups simultaneously in late 1996,911 and the basic molecular mechanism of a CAG expansion was confirmed. The range of expansion sizes on SCA2 chromosomes is 36 to 64 CAG repeats (mode, 38; mean, 41). The normal range is 14 to 31 CAG repeats, with 90% of normal chromosomes having 22 repeats and 7% having 23 repeats, while repeats of 32 to 34 CAGs compose an "intermediate range."12

We describe an Australian family of Italian extraction with ADCA I, subsequently demonstrated to be caused by SCA2. The clinical features within this pedigree are similar to those described in the literature with the exception that 5 of 6 members tested shared, to a greater or lesser extent, frontal-executive dysfunction in the presence of normal scores on the Mini-Mental State Examination (MMSE). A similar neuropsychological profile has recently been demonstrated in an SCA3 pedigree in which results of tests of learning and visual memory were normal, while deficits were shown in ability to shift attention to previously irrelevant stimulus dimensions and in the speed of visual information processing during high-demand tasks.13 We postulate that frontal-executive impairment, easily overlooked in the routine clinical setting, may be a common feature of the ADCAs.

DETECTION OF CAG EXPANSION IN SCA2 GENE

Patients had their DNA analyzed by means of the oligonucleotides SCA2-A and SCA2-B.10 These primers gave a product of 61 bp+3n bp (where n equals the number of CAG repeats). Reactions contained 10 ng of genomic DNA, 0.2-mmol/L each deoxynucleotide triphosphate, 0.5-µg SCA2-A, 3.0-mmol/L magnesium sulfate, 10% dimethyl sulfoxide, and 0.5 U of Taq polymerase (Boehringer Mannheim, Mannheim, Germany) in a final volume of 20 µL. One microgram of the reverse primer, SCA2-B, was end-labeled in a kinase reaction with phosphorus γ33 (γ33P)–labeled deoxyadenosine triphosphate (7400×1010 Bq/mmol). Other conditions were as recommended by the manufacturer. Thirty cycles were performed, each involving 95°C for 1 minute, 65°C for 1 minute, and 72°C for 2 minutes. An aliquot was analyzed on an 8% denaturing polyacrylamide gel. The gel was fixed, dried, and exposed for autoradiography for 48 hours at room temperature. The size of the expansion was determined relative to the M13 sequencing ladder, which was used as the molecular weight marker. Errors in estimation of triplet repeat expansion numbers were ±1 repeat in the expanded range.

NEUROPSYCHOLOGICAL TESTS

The MMSE14 was administered in the standardized fashion, with serial 7's used for the so-called attention section, rather than the alternative of spelling "WORLD" backward. The United Kingdom version of the National Adult Reading Test was used as an estimate of premorbid full-scale IQ and was administered and scored according to the publisher's instructions.15 The utility of this test was well discussed by Crawford.16 Although dementia and possibly even dysarthria might lower National Adult Reading Test scores, the purpose of performing this test was to demonstrate that premorbid intelligence in our patient sample was at least within the average range. As both of these potential confounding factors would tend to lower scores, the assertion that our patients had at least average premorbid abilities (see the "Results" section) is sustainable. The F, A, S test of verbal fluency by initial letter was performed and scored as laid out by Spreen and Strauss.17 Although cerebellar dysarthria might interfere with performance on this test, the production rate was slow enough in each case (not more than 38 words in 3 minutes in any case) that pauses constituted most of the time allowed. It was judged unlikely that a slow production rate was attributable to dysarthria in any of our patients. The Victoria version of the Stroop test was administered according to the instructions of Spreen and Strauss.17 Their normative data were used for scoring, but the "W" condition (reading the ink colors of non–color-name words) was used as a control for the conflicting ("C") condition by subtracting the z score of the former from the latter. The effect of this manipulation in this timed test is to allow for the potential reduction in visual scanning and speech production speeds in ataxic, dysarthric patients. The Wisconsin Card Sorting Test was administered and scored according to the distributor's instructions (Psychological Assessment Resources Inc, Odessa, Fla). Categories achieved, trials to first category, total errors, perseverative responses, perseverative and nonperseverative errors, failures to maintain set, and percentage of conceptual level responses were analyzed for each subject. As it is an untimed task, with no premium on motor accuracy, its interpretation should not be confounded in this patient population.

Three bedside tests of motor regulation, based on the work of Luria,18 were used. The "conflicting tapping" test requires the patient to tap twice when the examiner taps once, and vice versa. If the patient tapped 1 for 1 and/or 2 for 2 with the examiner, despite being able to repeat the instructions afterward, the test was considered failed. Luria's bimanual alternation (or "alternating hand movements") test requires the patient to make a fist with one hand while opening the other, and then reverse this process, over at least 10 trials. If the patient displayed similar rather than contrary motion in the 2 hands, the test was recorded as failed. The version of Luria's fist-palm-side (or "3-step") test used requires patients to say the sequence as they perform it for at least 10 cycles. Persistent simplification or missequencing of the target pattern was scored as a failure. Failure was also scored if the verbal sequence was correct and in conflict with each error. While all 3 tests are motor tasks, in each case the type of movement rather than its speed or accuracy was assessed, and it was considered that this was unlikely to be confounded by cerebellar motor deficits.

CLINICAL ASSESSMENT OF VESTIBULO-OCULAR REFLEX

Best-corrected visual acuity in both eyes together was established on a Snellen chart, and the head then oscillated passively through approximately 20° of yaw at approximately 2 Hz. During this oscillation, visual acuity in both eyes together was reassessed. A decrease of up to 1 line in visual acuity is considered normal,19 and a loss of 2 lines was interpreted as a borderline result. The Zee test19 was performed by observing one optic disc ophthalmoscopically, with the patient covering the other eye and attempting to fix an imaginary distant target, while the examiner oscillated the patient's head in yaw at about 2 Hz. The disc should remain stable relative to the examiner's line of sight if the vestibulo-ocular reflex gain is normal (approximately 0.8). If the gain is abnormally low, the disc appears to move in the opposite direction from the orbit, as the globe moves with the head. If the gain is abnormally high, the disc appears to move in the same direction as the orbit.

MAGNETIC RESONANCE IMAGING

Sagittal magnetic resonance (MR) images were obtained with a 0.3-T magnet (Fonar, Melville, NY) (echo time, 30 milliseconds; repetition time, 500 milliseconds; number of excitations, 2) for individuals IV-1 and V-1. A 1.5-T magnet (Signa, General Electric Co, Milwaukee, Wis) (echo time, 10 milliseconds; repetition time, 500 milliseconds; number of excitations, 1) was used for individual V-2.

PEDIGREE AND RESULTS OF SCA2 GENE TESTING

The pedigree of the family is shown in Figure 1, and the molecular analysis of the SCA2 CAG expansion in 6 of the 8 tested individuals is shown in Figure 2. Our study is restricted to the Australian branch of the family, the descendants of individual II-1. We noted a tight inverse correlation between CAG repeat number and reported age at onset (Figure 3), especially for repeat numbers of less than 40 to 42, an observation that is well documented in larger studies.20,21 As is also consonant withthe observations of others, the present pedigree appears to display anticipation. Three child-parent pairs (IV-1 and V-1, IV-3 and V-5, and IV-9 and V-13) had recorded ages at onset, and the ages in the children were younger than the parents by 14, 11, and 26 years, respectively. These 3 pairs show increases in repeat size from parent to child of +1, +6, and +1, respectively.

Place holder to copy figure label and caption
Figure 1.

Pedigree of the family, excluding descendants of presumed unaffected members. Solid symbols indicate known or presumed affected members. Individuals with asterisks were personally examined; subject IV-3 died soon thereafter. Information on the clinical state of other members is anecdotal. Bull's-eye symbol indicates asymptomatic obligate heterozygote. Deceased status (diagonal line) shown for the Australian branch (descendants of subject II-1) only.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Detection of CAG expansion in affected individuals. Track 1, Individual IV-9, 22 of 38 repeats; track 2, individual IV-1, 22 of 39 repeats; track 3, individual V-1, 22 of 40 repeats; track 4, individual V-2, 22 of 44 repeats; track 5, individual IV-3, 22 of 41 repeats; and track 6, individual V-5, 23 of 47 repeats.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Scatterplot diagram showing the inverse relationship between CAG repeat number and age at onset. This was significant, with a Spearman rank correlation coefficient of 0.83 and a 2-tailed P value of .02 (exact significance for n=8).

Graphic Jump Location
CLINICAL FEATURES

The clinical features of the pedigree are shown in Table 1. The average age at onset was 33.5 years (range, 21-46 years), and the duration of illness when the person was examined ranged from 4 to 20 years. One individual, IV-3, died after being examined but before this article was prepared. The pattern of clinical findings in our pedigree matches that in the literature quite closely. To establish this, published series7,2026 were pooled, and the frequency of each finding was expressed as a percentage of the total number of patients in all the series in which it was commented on. We assumed that the report by Cancel et al21 included the patients described by Dürr et al27 and Belal et al,28 because of common authorship. Although the reports by Pulst et al7 and Geschwind et al22 do share common authorship, the families are distinct (Dan Geschwind, MD, PhD, written communication, March 1998) and have been tabulated separately. This analysis gave the results shown in Table 2.

Table Graphic Jump LocationTable 1. Clinical Features of Spinocerebellar Ataxia Type 2 Pedigree
Table Graphic Jump LocationTable 2. Pattern of Clinical Findings in Relation to Published Series

Of course, ataxia was virtually universal and indeed was the defining feature for inclusion as "affected" in our pedigree. In addition, the symptom of dysphagia was reported in 45% of the 198 cases from the pooled series in which this information was recorded and in 4 (50%) of our own series. It can be seen that, with the exception of vibratory sense loss in the lower limbs, the clinical findings in our pedigree closely reflect those in the literature. However, with the possible exception of oculomotor abnormalities,29,30 the other features reported in Table 2 have not proved reliable in distinguishing between the various ADCA I genotypes.30

EYE MOVEMENTS AND NEUROIMAGING

The results of clinical assessment of eye movements are shown in Table 3. It is notable that no patient complained of spontaneous or movement-induced oscillopsia on inquiry, and no patient had spontaneous nystagmus with fixation while sitting erect, although 1 (individual V-5) developed downbeating nystagmus and vertigo on attempting to lie flat (supine) for MR imaging. In this context, the sagittal MR images in the 3 of our patients in whom they were obtained (IV-1, V-1, and V-2; Figure 4) are of interest. Atrophy of cerebellar hemispheres, vermis, middle cerebellar peduncles, and medulla and upper spinal cord were present in each case. It can also be seen that the 2 patients with SCA2 who had marked saccadic slowing (IV-1 and V-2) had more severe pontine atrophy and more marked cerebellar vermian atrophy than patient V-1. In both cases the inferior vermis was more atrophic than the superior. Although sparing of the flocculonodular lobe has been reported pathologically in SCA,25,27 the resolution of these scans was insufficient to establish such sparing in our patients.

Table Graphic Jump LocationTable 3. Clinical Assessment of Eye Movements*
Place holder to copy figure label and caption
Figure 4.

Sagittal magnetic resonance images of patients IV-1 (A), V-1 (B), and V-2 (C). Sagittal sequences best show the pontine, medullary, and vermian changes; note particularly the flattening of the anterior surface of the pons and considerable increase in the volume of the prepontine cistern and cisterna magna.

Graphic Jump Location
NEUROPSYCHOLOGICAL FEATURES

The results of limited neuropsychological testing of these patients is shown in Table 4. In the 6 in whom it could be assessed with the National Adult Reading Test, estimated premorbid IQ was within the average range. The MMSE was above the usual cutoff (of 24) in all 7 patients who consented to its performance. Despite this, of the 6 in whom standardized tests assessing some aspect of frontal-executive function were performed, 5 were at 4 SDs below the published means for controls matched for age, sex, and educational attainment on at least 1 measure. Of the measures used, uncorrected error rate on the conflicting portion of the Stroop test was the most consistently and severely abnormal (Table 4). This is not a measure that would be expected a priori to be impaired as a consequence of cerebellar-related motor deficit. Of the 7 affected individuals in whom Luria's motor regulation tasks were administered, 5 failed at least 1 of these 3 tasks (Table 4). Interestingly, each of the 3 tasks was passed by at least 1 patient who failed at least 1 of the others, which would not have been expected had 1 or more been confounded by the patients' shared cerebellar motor deficit. Three individuals also displayed behavior that was judged subjectively to be impulsive. Indeed, it was this observation in individual V-2 that led to the systematic investigation of all testable, consenting family members.

Table Graphic Jump LocationTable 4. Results of Neuropsychological Testing*
NEURO-OTOLOGIC AND NEURORADIOLOGICAL CHARACTERISTICS

Of the published series of patients with SCA2, only 1 addressed the vestibulo-ocular reflex gain.20 It was found to be impaired in 10 of 14 patients, although the assessment method used was not stated. We found no evidence of nystagmus, and little evidence of abnormal vestibulo-ocular reflex gain, in any of our patients with the use of 2 simple bedside tests. This is in marked contrast to the findings in some other cerebellar cortical degenerations, such as SCA6.31 It is tempting to speculate that the relative sparing of the flocculonodular lobe described neuropathologically5,27 underlies the relative scarcity of "cerebellar" eye movement disorders in SCA2; disease of this portion of the cerebellum appears to underlie many of these abnormalities of ocular motility.32,33 Unfortunately, the resolution of the MR images available to us was insufficient to demonstrate sparing of the archicerebellum. As has been pointed out recently by Bürk et al,34 the typical patient with SCA2 displays global cerebellar and pontine atrophy, which reflects the reported pathological features, and may aid differentiation from SCA3. The results of MR imaging in our patients with SCA2 conform to their findings.

NEUROPSYCHOLOGICAL FEATURES

The clinical features of SCA2 in 111 patients from 32 families have recently been tabulated,21 with a reported frequency of "mental deterioration" of 14%, including 4% who displayed only "memory loss." This was in contrast to the findings in the original Cuban pedigree, where "dementia" occurred in only 1 of 263 affected pedigree members.26 Subsequent reports of other pedigrees between 1993 and 1995, comprising 98 patients in total, failed to mention cognitive impairment or dementia as a feature of SCA2.7,2325,28 Dürr et al27 reported 3 SCA2 pedigrees from Martinique, with dementia occurring in only 1 of these families. Geschwind et al22 noted dementia in 6 of their 16 American patients with SCA2, apparently all from the same early-onset African American pedigree. The nature of the dementia was not specified in the report but consisted of a history indicative of frontal-subcortical dementia, progressing rapidly to global dementia that had supervened in each case before assessment could be undertaken (Dan Geschwind, MD, PhD, written communication, March 1998). Schöls et al20 recently reported that "mild dementia was suspected clinically in 5 [of 21 SCA2] patients," with "poor memory, concentration problems, deficits in cognitive function, and emotional instability." Cancel et al21 related "memory loss or dementia" in patients with SCA2 to duration of illness; those without such impairment had a mean disease duration of 10.8±7.0 years, whereas those with these features had a mean disease duration of 17.3±9.0 years.21 There was no correlation with CAG repeat length, and no mention was made of a correlation with ataxia severity, which is likely to depend on both CAG repeat length and duration of illness. Kish et al35 had previously reported that the degree of cognitive impairment correlated with ataxia severity in a heterogeneous group of patients with SCA.35 Interestingly, this impairment involved executive control, with more generalized cognitive dysfunction appearing in addition in some of the most severely affected patients. This suggestion of frontal-executive dysfunction in the SCAs has been confirmed for SCA3 (Machado-Joseph disease) by means of a different battery of neuropsychological tests, in a detailed study of 6 patients from 1 pedigree.13 The authors concluded that specific cognitive deficits occur in SCA3, which may reflect disruption of frontosubcortical pathways, independent of motor dysfunction.

It is against this background that the results of our study must be interpreted. Only 1 of our 8 patients (individual IV-3) was apparently demented to standard clinical observation during neurological examination, and the severity of her motor dysfunction was such that this impression may have been erroneous and would have been impossible to test. A second patient (individual V-2) displayed obvious impulsivity, with behavior that endangered self and others. Frontal-executive dysfunction was strongly suspected but could not be unequivocally confirmed, as she declined testing. This interaction stimulated us to look more closely at the remaining pedigree members. In keeping with the tenor of most previous reports, none had an MMSE score below 25 and might therefore have been classified as nondemented, even if clinical assessment had included this simple global measure. However, all except individual IV-1 produced clearly abnormal results on at least 1 of the verbal fluency (F, A, S), modified Stroop (error rate), and Wisconsin Card Sorting tests. The last is independent of output speed, and the Stroop test can be rendered so by subtracting the nonconflicting from the conflicting condition. In addition, 4 of 6 subjects produced at least 1 abnormal qualitative result on Luria's tests of motor regulation. Although such tests might be thought to be invalidated by cerebellar motor dysfunction, they are untimed, and movement type rather than movement accuracy is assessed. In addition, although all patients had various degrees of severity of the same motor deficit, there was no hierarchical pattern of failure on these tests. Both of these factors suggest that the results of such testing are valid in this patient population. We suggest that frontal-executive dysfunction may be common in SCA2 and is perhaps currently being overlooked, as it can be present in the absence of overt dementia. Patients from different family and ethnic backgrounds need to be tested to confirm this conclusion, however, especially in view of the reported interfamily variation in dementia rates in SCA2, and as it is unclear whether the frontal-executive dysfunction reported herein represents a milder form of SCA2 dementia or an independently occurring entity.

The disparity between MMSE scores and results of frontal-executive function testing is hardly surprising: the MMSE is notably insensitive to impairment of such functions (eg, see Royall et al36). This result should simply serve to alert clinicians who care for these patients that the frequency of cognitive impairment may previously have been underestimated in SCA2, and to reinforce the dictum that a normal MMSE score does not guarantee a cognitively intact patient.

Perhaps of more interest is that the frontal-executive dysfunction documented in this study helps to advance the case for such deficits being common to the patients with ADCA as a group.13,35 Indeed, there has been increasing interest of late in the possibility of a significant cerebellar contribution to cognition,37 and although the field is beset by controversy,3840 a recent review has concluded that it is increasingly difficult to ignore the weight of evidence from converging methods, including functional imaging studies in normal individuals, in favor of the cerebellum playing such a role.41 While a broad range of tasks has been investigated in patients with cerebellar dysfunction, Fiez41 characterized those to which the cerebellum seems to contribute as being "initially effortful and in which correct responses are self-discovered (typically through trial and error), but that are performed more automatically (more smoothly, quickly and accurately) following practice." It is easy to envisage how disruption of such a system for learning novel tasks could result in impairment of the ability to perform the Wisconsin Card Sorting Test, to suppress usual responses in favor of novel responses efficiently in the modified Stroop test, or to search the lexicon in a novel fashion in the F, A, S test. In other words, cerebellar dysfunction might result in a "frontal-executive dysfunction" syndrome. However, the burden of neuronal loss in SCA2, as for the other causes of ADCAs I and 2II, is not confined to the cerebellum. Maruff et al13 speculated that the deficits that they documented in SCA3 (Machado-Joseph disease) were caused by disruption of frontal-subcortical systems,13 and neuropathological findings in the few cases of SCA2 where they have been reported show that while the pallidoluysian system is much less severely involved than in SCA3, the substantia nigra is involved in both.5,27,42 Therefore, it is also possible that the frontal-executive dysfunction in our patients with SCA2 has a cause not directly related to their cerebellar abnormality, and its presence does not contribute strongly to the debate. In this regard, a careful neuropsychological study of patients with SCA6 (where the neuronal damage is more closely confined to the cerebellar cortex and inferior olivae) may be informative and should be undertaken.

The relationship between repeat number and degree of frontal-executive dysfunction is not capable of formal analysis in this study, as all but 1 of the 6 affected family members assessed showed evidence of frontal-executive impairment, and as no single or composite scale of frontal-executive dysfunction was used. Nevertheless, there is no clear correlation between repeat number and the results of individual tests of frontal-executive function. This extends the findings of Cancel et al21 in this regard, who found no clear correlation between dementia and repeat number in SCA2.

NOTE ADDED IN PROOF

In addition, since submission of this manuscript, Gambardella et al43 have reported early and selective impairment of performance on the Wisconsin Card Sorting Test in 3 Italian families with SCA2.

Accepted for publication May 19, 1998.

The Murdoch Institute, Parkville, Australia, is a block-funded institute of the National Health and Medical Research Council of Australia, Canberra.

We thank Jean-Louis Mandel, MD, PhD, for helpful advice and access to molecular information.

Reprints: Elsdon Storey, PhD, Department of Neuroscience, Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia (e-mail: Elsdon.storey@med.monash.edu.au).

Storey  E Dominantly inherited ataxias (part I). J Clin Neurosci. 1998;5257- 264
Link to Article
Zhuchenko  OBailey  JBonnen  P  et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat Genet. 1997;1562- 69
Link to Article
Harding  AE The clinical features and classification of the late onset autosomal dominant cerebellar ataxias: a study of 11 families, including descendants of "the Drew family of Walworth." Brain. 1982;1051- 28
Link to Article
Wadia  NHSwami  RK A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families). Brain. 1971;94359- 374
Link to Article
Orozco  GEstrada  RPerry  TL  et al.  Dominantly inherited olivopontocerebellar atrophy from eastern Cuba: clinical, neuropathological, and biochemical findings. J Neurol Sci. 1989;9337- 50
Link to Article
Gispert  STwells  ROrozco  G  et al.  Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet. 1993;4295- 299
Link to Article
Pulst  S-MNechiporuk  AStarkman  S Anticipation in spinocerebellar ataxia type 2. Nat Genet. 1993;58- 10
Link to Article
Trottier  YLutz  YStevanin  G  et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 1995;378403- 406
Link to Article
Imbert  GSaudou  FYvert  G  et al.  Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet. 1996;14285- 291
Link to Article
Pulst  S-MNechiporuk  ANechiporuk  T  et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14269- 276
Link to Article
Sanpei  KTakano  HIgarashi  S  et al.  Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet. 1996;14277- 284
Link to Article
Riess  OLaccone  FAGispert  S  et al.  SCA2 trinucleotide expansion in German SCA patients. Neurogenetics. 1997;159- 64
Link to Article
Maruff  PTyler  PBurt  TCurrie  BBurns  CCurrie  J Cognitive deficits in Machado-Joseph disease. Ann Neurol. 1996;40421- 427
Link to Article
Folstein  MFFolstein  SEMcHugh  PR "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12189- 198
Link to Article
Nelson  HE The National Adult Reading Test (NART): Test Manual.  Windsor, England NFER-Nelson Publishing Co Ltd1992;
Crawford  JR Current and premorbid intelligence measures in neuropsychological assessment. Crawford  JFParker  DMMcKinlay  WWeds.A Handbook of Neuropsychological Assessment Hove, England Lawrence Erlbaum Associates1992;21- 49
Spreen  OStrauss  E A Compendium of Neuropsychological Tests: Administration Norms, and Commentary.  New York, NY Oxford University Press1991;52- 56221- 229
Luria  AR Higher Cortical Functions in Man.  New York, NY Basic Books Inc1980;415- 435
Zee  DSFletcher  WA Bedside examination. Baloh  RWHalmagyi  GMeds.Disorders of the Vestibular System New York, NY Oxford University Press1996;178- 190
Schöls  LGispert  SVorgerd  M  et al.  Spinocerebellar ataxia type 2: genotype and phenotype in German kindreds. Arch Neurol. 1997;541073- 1080
Link to Article
Cancel  GDürr  ADidierjean  O  et al.  Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet. 1997;6709- 715
Link to Article
Geschwind  DHPerlman  SFigueroa  CPTreiman  LJPulst  SM The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997;60842- 850
Giunti  PSweeney  MGHarding  AE Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth. Brain. 1995;1131077- 1085
Link to Article
Filla  ADe Michele  GBanfi  S  et al.  Has spinocerebellar ataxia type 2 a distinct phenotype? genetic and clinical study of an Italian family. Neurology. 1995;45793- 796
Link to Article
Lopes-Cendes  IAndermann  EAttig  E  et al.  Confirmation of the SCA-2 locus as an alternative locus for dominantly inherited spinocerebellar ataxias and refinement of the candidate region. Am J Hum Genet. 1994;54774- 781
Orozco Diaz  GNodarse Fleites  ACordovés Sagaz  RAuburger  G Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba. Neurology. 1990;401369- 1375
Link to Article
Dürr  ASmadja  DCancel  G  et al.  Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain. 1995;1181573- 1581
Link to Article
Belal  SCancel  GStevanin  G  et al.  Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus. Neurology. 1994;441423- 1426
Link to Article
Rivaud-Pechoux  SDürr  AGaymard  B  et al.  Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I. Ann Neurol. 1998;43297- 302
Link to Article
Schöls  LAmoiridis  GBüttner  TPrzuntek  HEpplen  JTRiess  O Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol. 1997;42924- 932
Link to Article
Gomez  CMThompson  RMGammack  JT  et al.  Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol. 1997;42933- 950
Link to Article
Leigh  RJZee  DS The Neurology of Eye Movements. 2nd ed. Philadelphia, Pa FA Davis Co1991;424- 425
Hirose  GHalmagyi  GM Brain tumours and balance disorders. Baloh  RWHalmagyi  GMeds.Disorders of the Vestibular System New York, NY Oxford University Press1996;446- 460
Bürk  KAbele  MFetter  M  et al.  Autosomal dominant cerebellar ataxia type I: clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996;1191497- 1505
Link to Article
Kish  SJEl-Awar  MStuss  D  et al.  Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia: relationship to ataxia severity. Neurology. 1994;441738- 1746
Link to Article
Royall  DRMahurin  RKCornell  J Bedside assessment of frontal degeneration: distinguishing Alzheimer's disease from non-Alzheimer's cortical dementia. Exp Aging Res. 1994;2095- 103
Link to Article
Schmahman  JD An emerging concept: the cerebellar contribution to higher function. Arch Neurol. 1991;481178- 1187
Link to Article
Leiner  HCLeiner  ALDow  RS Cognitive and language functions of the human cerebellum. Trends Neurosci. 1993;16444- 447453- 454
Link to Article
Ito  M Movement and thought: identical control mechanisms by the cerebellum. Trends Neurosci. 1993;15448- 450
Link to Article
Glickstein  M Motor skills but not cognitive tasks. Trends Neurosci. 1993;16450- 452
Link to Article
Fiez  J Cerebellar contributions to cognition. Neuron. 1996;1613- 15
Link to Article
Sasaki  HWakisaka  ATashiro  KHamada  TShima  K Clinical study of gene locus heterogeneity in hereditary olivopontocerebellar atrophy (OPCA): report of 2 pedigrees affected with non-SCA1 type OPCA. Clin Neurol. 1991;311170- 1176
Gambardella  AAnnesi  GBono  F  et al.  CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2)–early impairment of Wisconsin Card Sorting Test and saccade velocity. J Neurol. 1998;245647- 652
Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.

Pedigree of the family, excluding descendants of presumed unaffected members. Solid symbols indicate known or presumed affected members. Individuals with asterisks were personally examined; subject IV-3 died soon thereafter. Information on the clinical state of other members is anecdotal. Bull's-eye symbol indicates asymptomatic obligate heterozygote. Deceased status (diagonal line) shown for the Australian branch (descendants of subject II-1) only.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Detection of CAG expansion in affected individuals. Track 1, Individual IV-9, 22 of 38 repeats; track 2, individual IV-1, 22 of 39 repeats; track 3, individual V-1, 22 of 40 repeats; track 4, individual V-2, 22 of 44 repeats; track 5, individual IV-3, 22 of 41 repeats; and track 6, individual V-5, 23 of 47 repeats.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Scatterplot diagram showing the inverse relationship between CAG repeat number and age at onset. This was significant, with a Spearman rank correlation coefficient of 0.83 and a 2-tailed P value of .02 (exact significance for n=8).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

Sagittal magnetic resonance images of patients IV-1 (A), V-1 (B), and V-2 (C). Sagittal sequences best show the pontine, medullary, and vermian changes; note particularly the flattening of the anterior surface of the pons and considerable increase in the volume of the prepontine cistern and cisterna magna.

Graphic Jump Location

Tables

Table Graphic Jump LocationTable 1. Clinical Features of Spinocerebellar Ataxia Type 2 Pedigree
Table Graphic Jump LocationTable 2. Pattern of Clinical Findings in Relation to Published Series
Table Graphic Jump LocationTable 3. Clinical Assessment of Eye Movements*
Table Graphic Jump LocationTable 4. Results of Neuropsychological Testing*

References

Storey  E Dominantly inherited ataxias (part I). J Clin Neurosci. 1998;5257- 264
Link to Article
Zhuchenko  OBailey  JBonnen  P  et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat Genet. 1997;1562- 69
Link to Article
Harding  AE The clinical features and classification of the late onset autosomal dominant cerebellar ataxias: a study of 11 families, including descendants of "the Drew family of Walworth." Brain. 1982;1051- 28
Link to Article
Wadia  NHSwami  RK A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families). Brain. 1971;94359- 374
Link to Article
Orozco  GEstrada  RPerry  TL  et al.  Dominantly inherited olivopontocerebellar atrophy from eastern Cuba: clinical, neuropathological, and biochemical findings. J Neurol Sci. 1989;9337- 50
Link to Article
Gispert  STwells  ROrozco  G  et al.  Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet. 1993;4295- 299
Link to Article
Pulst  S-MNechiporuk  AStarkman  S Anticipation in spinocerebellar ataxia type 2. Nat Genet. 1993;58- 10
Link to Article
Trottier  YLutz  YStevanin  G  et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 1995;378403- 406
Link to Article
Imbert  GSaudou  FYvert  G  et al.  Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet. 1996;14285- 291
Link to Article
Pulst  S-MNechiporuk  ANechiporuk  T  et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14269- 276
Link to Article
Sanpei  KTakano  HIgarashi  S  et al.  Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet. 1996;14277- 284
Link to Article
Riess  OLaccone  FAGispert  S  et al.  SCA2 trinucleotide expansion in German SCA patients. Neurogenetics. 1997;159- 64
Link to Article
Maruff  PTyler  PBurt  TCurrie  BBurns  CCurrie  J Cognitive deficits in Machado-Joseph disease. Ann Neurol. 1996;40421- 427
Link to Article
Folstein  MFFolstein  SEMcHugh  PR "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12189- 198
Link to Article
Nelson  HE The National Adult Reading Test (NART): Test Manual.  Windsor, England NFER-Nelson Publishing Co Ltd1992;
Crawford  JR Current and premorbid intelligence measures in neuropsychological assessment. Crawford  JFParker  DMMcKinlay  WWeds.A Handbook of Neuropsychological Assessment Hove, England Lawrence Erlbaum Associates1992;21- 49
Spreen  OStrauss  E A Compendium of Neuropsychological Tests: Administration Norms, and Commentary.  New York, NY Oxford University Press1991;52- 56221- 229
Luria  AR Higher Cortical Functions in Man.  New York, NY Basic Books Inc1980;415- 435
Zee  DSFletcher  WA Bedside examination. Baloh  RWHalmagyi  GMeds.Disorders of the Vestibular System New York, NY Oxford University Press1996;178- 190
Schöls  LGispert  SVorgerd  M  et al.  Spinocerebellar ataxia type 2: genotype and phenotype in German kindreds. Arch Neurol. 1997;541073- 1080
Link to Article
Cancel  GDürr  ADidierjean  O  et al.  Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet. 1997;6709- 715
Link to Article
Geschwind  DHPerlman  SFigueroa  CPTreiman  LJPulst  SM The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997;60842- 850
Giunti  PSweeney  MGHarding  AE Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth. Brain. 1995;1131077- 1085
Link to Article
Filla  ADe Michele  GBanfi  S  et al.  Has spinocerebellar ataxia type 2 a distinct phenotype? genetic and clinical study of an Italian family. Neurology. 1995;45793- 796
Link to Article
Lopes-Cendes  IAndermann  EAttig  E  et al.  Confirmation of the SCA-2 locus as an alternative locus for dominantly inherited spinocerebellar ataxias and refinement of the candidate region. Am J Hum Genet. 1994;54774- 781
Orozco Diaz  GNodarse Fleites  ACordovés Sagaz  RAuburger  G Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba. Neurology. 1990;401369- 1375
Link to Article
Dürr  ASmadja  DCancel  G  et al.  Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain. 1995;1181573- 1581
Link to Article
Belal  SCancel  GStevanin  G  et al.  Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus. Neurology. 1994;441423- 1426
Link to Article
Rivaud-Pechoux  SDürr  AGaymard  B  et al.  Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I. Ann Neurol. 1998;43297- 302
Link to Article
Schöls  LAmoiridis  GBüttner  TPrzuntek  HEpplen  JTRiess  O Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol. 1997;42924- 932
Link to Article
Gomez  CMThompson  RMGammack  JT  et al.  Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol. 1997;42933- 950
Link to Article
Leigh  RJZee  DS The Neurology of Eye Movements. 2nd ed. Philadelphia, Pa FA Davis Co1991;424- 425
Hirose  GHalmagyi  GM Brain tumours and balance disorders. Baloh  RWHalmagyi  GMeds.Disorders of the Vestibular System New York, NY Oxford University Press1996;446- 460
Bürk  KAbele  MFetter  M  et al.  Autosomal dominant cerebellar ataxia type I: clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996;1191497- 1505
Link to Article
Kish  SJEl-Awar  MStuss  D  et al.  Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia: relationship to ataxia severity. Neurology. 1994;441738- 1746
Link to Article
Royall  DRMahurin  RKCornell  J Bedside assessment of frontal degeneration: distinguishing Alzheimer's disease from non-Alzheimer's cortical dementia. Exp Aging Res. 1994;2095- 103
Link to Article
Schmahman  JD An emerging concept: the cerebellar contribution to higher function. Arch Neurol. 1991;481178- 1187
Link to Article
Leiner  HCLeiner  ALDow  RS Cognitive and language functions of the human cerebellum. Trends Neurosci. 1993;16444- 447453- 454
Link to Article
Ito  M Movement and thought: identical control mechanisms by the cerebellum. Trends Neurosci. 1993;15448- 450
Link to Article
Glickstein  M Motor skills but not cognitive tasks. Trends Neurosci. 1993;16450- 452
Link to Article
Fiez  J Cerebellar contributions to cognition. Neuron. 1996;1613- 15
Link to Article
Sasaki  HWakisaka  ATashiro  KHamada  TShima  K Clinical study of gene locus heterogeneity in hereditary olivopontocerebellar atrophy (OPCA): report of 2 pedigrees affected with non-SCA1 type OPCA. Clin Neurol. 1991;311170- 1176
Gambardella  AAnnesi  GBono  F  et al.  CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2)–early impairment of Wisconsin Card Sorting Test and saccade velocity. J Neurol. 1998;245647- 652
Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

721 Views
49 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have a Family History of Cancer?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have a Family History of Cancer?

×